A prospective metanalysis of clinical trials examined the effects of high and low doses of anticoagulation for hospitalized ...

For patients hospitalized for COVID-19, administration of therapeutic-dose versus prophylactic-dose anticoagulation with ...

The following is a summary of “Early vs Late Anticoagulation After Ischemic Stroke in Patients With Atrial Fibrillation and ...

An analysis of genetic sequencing data and gene and protein expression studies from patients with yellow nail syndrome (YNS) found that defects in the planar cell polarity (PCP) pathway play a ...

"Associations between dose of anticoagulation and outcome appeared broadly consistent across all predefined patient subgroups ...

In this meta-analysis of randomized trials involving patients hospitalized with COVID-19, therapeutic-dose anticoagulation ...

The following is a summary of “Low Incidence of Delayed Intracranial Hemorrhage in Geriatric Emergency Department Patients on ...

JANESVILLE -- Mercyhealth has successfully performed its 500th Watchman procedure.

Dan Bloomfield, MD, chief medical officer, Anthos, walks through promising findings demonstrating the efficacy of abelacimab, ...

A pair of Regeneron’s monoclonal antibodies have held their own against a commonly used anticoagulant in a phase 2 trial, ...

Caroline Block, MD, Clinical Director of the Breast Oncology Program at Dana-Farber Cancer Institute has been selected by The ...

Noninferiority of reduced- versus full-dose anticoagulants cannot be proven in patients with venous thromboembolism who need extended anticoagulation.